Any news on the Discovery R&D side of things?

[anonymous]

How are things in preclinical research?

 

[anonymous]

How are things in preclinical research?

Yea our “research lab in New Brunswick just took delivery of our annual albino mouse allotment from Charles River to test toxicity of all the “new” compounds coming through the pipeline.

The team is very exicited!

 

[anonymous]

Yeah, they just discovered that they are truly screwed once they lose all these patents, hence the mass layoffs last year.

 

[anonymous]

Just remember that J&J is turning its R&D to S&D (search and discover) by buying out assets from smaller companies and quickly developing them for entry into clinical trials. Not much in terms of existing FTE resources will be needed moving forward so be on the lookout for additional cuts this year.

 

[anonymous]

Just remember that J&J is turning its R&D to S&D (search and discover) by buying out assets from smaller companies and quickly developing them for entry into clinical trials. Not much in terms of existing FTE resources will be needed moving forward so be on the lookout for additional cuts this year.

In La Jolla, California, we had a big day today because we got our annual one albino mouse that will be using for all testing of toxicity liver target for the new compound that might be coming out sometime this year other than that we’re sitting around waiting for something to come across our lab bench.

 

[anonymous]

Just remember that J&J is turning its R&D to S&D (search and discover) by buying out assets from smaller companies and quickly developing them for entry into clinical trials. Not much in terms of existing FTE resources will be needed moving forward so be on the lookout for additional cuts this year.

The fuck you talking about? JnJ hasn't put one internally derived drug to the market in its existence. It has always been "search and develop"